NeuroBo Pharmaceuticals CEO Hyung Kim's 2023 pay jumps 991% to $664K
NeuroBo Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 30, 2024
NeuroBo Pharmaceuticals reported fiscal year 2023 executive compensation information on April 30, 2024.
In 2023, four executives at NeuroBo Pharmaceuticals received on average a compensation package of $342K, a 22% increase compared to previous year.
Average pay of disclosed executives at NeuroBo Pharmaceuticals
Hyung Heon Kim, Chief Executive Officer, received $664K in total, which increased by 991% compared to 2022. 58% of Kim's compensation, or $387K, was in stock awards. Kim also received $55K in bonus, $174K in salary, as well as $48K in other compensation.
Joseph Hooker, Chief Executive Officer, received a compensation package of $432K. 100% of the compensation package, or $432K, was in other compensation.
Marshall Woodworth, Chief Financial Officer, earned $155K in 2023.
Gil Price, Chief Executive Officer, received $117K in 2023, which decreases by 77% compared to 2022.
Related executives
You may also like
Source: SEC filing on April 30, 2024.